Masimo [MASI] vs Abbott Laboratories [ABT] Detailed Stock Comparison

Masimo Corporation

NASDAQ
Loading...

Abbott Laboratories

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Masimo Corporation wins in 8 metrics, Abbott Laboratories wins in 11 metrics, with 0 ties. Abbott Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Masimo Corporation Abbott Laboratories Better
P/E Ratio (TTM) 46.47 25.97 Abbott Laboratories
Price-to-Book Ratio 12.89 3.09 Abbott Laboratories
Debt-to-Equity Ratio 77.55 26.79 Abbott Laboratories
PEG Ratio 27.03 -1.41 Masimo Corporation
EV/EBITDA 28.15 13.74 Abbott Laboratories
Profit Margin (TTM) -9.92% 13.90% Abbott Laboratories
Operating Margin (TTM) 18.52% 16.50% Masimo Corporation
EBITDA Margin (TTM) 18.52% 16.50% Masimo Corporation
Return on Equity 23.43% 12.36% Masimo Corporation
Return on Assets (TTM) 8.86% 7.52% Masimo Corporation
Free Cash Flow (TTM) $193.10M $7.40B Abbott Laboratories
Dividend Yield N/A 1.97% N/A
1-Year Return 11.63% -34.98% Masimo Corporation
Price-to-Sales Ratio (TTM) 6.12 3.57 Abbott Laboratories
Enterprise Value $9.72B $166.96B Abbott Laboratories
EV/Revenue Ratio 6.37 3.70 Abbott Laboratories
Gross Profit Margin (TTM) 59.95% N/A N/A
Revenue per Share (TTM) $28 $26 Masimo Corporation
Earnings per Share (Diluted) $3.84 $3.57 Masimo Corporation
Beta (Stock Volatility) 1.20 0.78 Abbott Laboratories
Short % of Float 6.81% 1.53% Abbott Laboratories

Masimo Corporation vs Abbott Laboratories Stock Performance Analysis

Loading Price Chart...

MASI
ABT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Masimo Corporation0.00%0.63%0.78%2.54%30.08%41.25%
Abbott Laboratories0.56%-2.02%4.97%-19.35%-30.98%-28.60%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Masimo Corporation11.63%11.44%-25.04%256.34%498.24%798.85%
Abbott Laboratories-34.98%-16.97%-20.08%135.84%255.56%329.52%

Performance & Financial Health Analysis: Masimo Corporation vs Abbott Laboratories

MetricMASIABT
Market Information
Market Cap i$9.36B$160.70B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i558,46313,495,583
90 Day Avg. Volume i1,362,54812,934,461
Last Close$179.95$88.67
52 Week Range$125.94 - $179.99$81.97 - $139.06
% from 52W High-0.02%-36.24%
All-Time High$305.21 (Nov 15, 2021)$142.60 (Dec 27, 2021)
% from All-Time High-41.04%-37.82%
Growth Metrics
Quarterly Revenue Growth0.12%0.08%
Quarterly Earnings GrowthN/A-0.19%
Financial Health
Profit Margin (TTM) i-0.10%0.14%
Operating Margin (TTM) i0.19%0.17%
Return on Equity (TTM) i0.23%0.12%
Debt to Equity (MRQ) i77.5526.79
Cash & Liquidity
Book Value per Share (MRQ)$13.84$30.02
Cash per Share (MRQ)$2.92$5.14
Operating Cash Flow (TTM) i$217.80M$10.80B
Levered Free Cash Flow (TTM) i$316.41M$13.77B
Dividends
Last 12-Month Dividend Yield iN/A1.97%
Last 12-Month Dividend i$0.00$2.40

Valuation & Enterprise Metrics Analysis: Masimo Corporation vs Abbott Laboratories

MetricMASI (Apr 24, 2026)ABT (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i46.4725.97
Forward P/E i27.0315.29
PEG Ratio i27.03-1.41
Price to Sales (TTM) i6.123.57
Price to Book (MRQ) i12.893.09
Market Capitalization
Market Capitalization i$9.36B$160.70B
Enterprise Value i$9.72B$166.96B
Enterprise Value Metrics
Enterprise to Revenue i6.373.70
Enterprise to EBITDA i28.1513.74
Risk & Other Metrics
Beta i1.200.78
Book Value per Share (MRQ) i$13.84$30.02

Financial Statements Comparison: Masimo Corporation vs Abbott Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMASI (2025)ABT (2025)
Revenue/Sales i1.53B44.33B
Cost of Goods Sold i581.70M19.32B
COGS % of Revenue i38.1%43.6%
Gross Profit i945.20M25.01B
Gross Margin i61.9%56.4%
Research & Development i126.40M2.94B
Operating Income (EBIT) i312.80M8.05B
Operating Margin i20.5%18.2%
EBITDA i355.00M12.03B
EBITDA Margin i23.2%27.1%
Pre-Tax Income i272.60M8.47B
Pre-Tax Income % of Revenue i17.9%19.1%
Income Tax i64.90M1.94B
Income Tax % of Revenue i4.3%4.4%
Net Income (Profit) i-151.50M6.52B
Profit Margin i-9.9%14.7%

Balance Sheet & Liquidity Metrics

MetricMASI (2025)ABT (2025)
Cash & Equivalents i152.30M8.52B
Total Current Assets i926.00M26.00B
Total Current Assets % of Revenue i60.6%58.6%
Total Current Liabilities i371.60M16.50B
Total Current Liabilities % of Revenue i24.3%37.2%
Long-Term Debt i544.90M10.83B
Long-Term Debt % of Revenue i35.7%24.4%
Total Shareholders Equity i721.20M52.77B
Retained Earnings i1.34B49.78B
Retained Earnings % of Revenue i87.7%112.3%
Property, Plant & Equipment i237.20M17.57B

Cash Flow Statement Comparison

MetricMASI (2025)ABT (2025)
Operating Cash Flow i198.40M10.80B
Operating Cash Flow % of Revenue i13.0%24.4%
Capital Expenditures i200,000-2.17B
Free Cash Flow i193.10M7.40B
FCF Margin i12.6%16.7%
Debt Repayment i-1.28B-1.50B
Common Stock Repurchase i-363.70M-893.00M

Short Interest & Institutional Ownership Analysis

MetricMASIABT
Shares Short i3.25M23.83M
Short Ratio i1.681.93
Short % of Float i6.81%1.53%
Shares Outstanding i52.10M1.74B
Float Shares i47.45M1.73B
% Held by Insiders i5.00%0.54%
% Held by Institutions i109.04%82.23%
% Held by Public i-14.04%17.23%

Dividend Analysis & Yield Comparison: Masimo Corporation vs Abbott Laboratories

MetricMASIABT
Last 12-Month Dividend i$0.00$2.40
Last 12-Month Dividend Yield iN/A1.97%
3-Year Avg Annual Dividend i$0.00$2.24
3-Year Avg Dividend Yield iN/A0.50%
3-Year Total Dividends i$0.00$6.72
Ex-Dividend DateN/AJan 15, 2026